Skip to content

LIEPHARM

Active Risk: not assessed Private limited companyfounded 2019active for 7 yearsPlace Joseph Meunier 11, 5640 MettetKBO/BCE: BE 0728.704.778

Board

1 director, since incorporation
Director (not named in the articles)
since 20-06-2019 term without a fixed end
listed in the 2025 annual accounts, filed on 29-07-2026

Office holders in the KBO →

Mandates through the years

1 name, the dashed line is today

Director (not named in the articles)
Board
Mandates as a list
    • Director (not named in the articles), from 20-06-2019 to date

Control

Founder
This company
LIEPHARM
Equity €119,377
Profit €64,975 in 2025

Capital

Contribution
€50,000
Shares
100
Contribution per share
€500
Equity per share
€1,194 in 2025
Source
deed of 24-12-2025

Articles of association

deed of 24-06-2019 (in French)
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
“Moitié cédant moitié acquéreurs proportionnellement actions acquises, commun accord ou président tribunal entreprise statuant comme en…”
Statutory auditorA statutory auditor is a registered auditor who checks the annual accounts. Small companies need not have one. According to the deed, the legal criteria do not require one here.
No statutory auditor

Shareholders

At incorporation deed of 24-06-2019 ↗
  • 100 shares (100%) · €50,000 in cash

Capital transactions

Capital over time
  1. 24-12-2025 Converted to available equity · €50,000
  2. 24-06-2019 Incorporation · €50,000 · 100 shares

Next steps